Why the study?
Does coronary artery calcification increase the risk of adverse events in patients treated with drug-coated balloon-only angioplasty?
Does coronary artery calcification increase the risk of adverse events in patients treated with drug-coated balloon-only angioplasty?
In patients treated with DCB-only angioplasty, coronary artery calcification increases the risk of target lesion failure and revascularization over 3 years, but does not substantially increase MACE or cardiac death.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Shan et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: